Amgen and Kyowa Kirin to Jointly Develop Potential First-In-Class Treatment for Atopic Dermatitis
Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083
Read moreAmgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083
Read moreNAVIGATOR Data Published in New England Journal of Medicine, and Latest Data from Tezepelumab Clinical Program ...
Read moreClinically Meaningful Improvements in Physician-Reported Outcomes Maintained Through Week 32 Consistent Efficacy Was Observed at Week ...
Read moreAmgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for investigational ...
Read moreAmgen Inc. and Rodeo Therapeutics Corporation today announced an agreement under which Amgen will acquire Rodeo, ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.